| Primary |
| Gastrooesophageal Reflux Disease |
49.1% |
| Dyspepsia |
9.5% |
| Hypertension |
7.4% |
| Rheumatoid Arthritis |
3.5% |
| Depression |
2.8% |
| Supplementation Therapy |
2.8% |
| Atrial Fibrillation |
2.5% |
| Gastritis |
2.5% |
| Pain |
2.5% |
| Ulcer |
2.5% |
| Barrett's Oesophagus |
2.1% |
| Crohn's Disease |
2.1% |
| Hypothyroidism |
1.8% |
| Osteoporosis |
1.8% |
| Anxiety |
1.4% |
| Blood Cholesterol |
1.4% |
| Blood Pressure Abnormal |
1.4% |
| Ankylosing Spondylitis |
1.1% |
| Back Pain |
1.1% |
| Bipolar Disorder |
1.1% |
|
| Pneumonia |
11.1% |
| Myocardial Infarction |
10.2% |
| Loss Of Consciousness |
7.4% |
| Weight Decreased |
6.5% |
| Pruritus |
5.6% |
| Cerebrovascular Accident |
4.6% |
| Diarrhoea |
4.6% |
| Drug Ineffective |
4.6% |
| Headache |
4.6% |
| Nephritis Interstitial |
4.6% |
| Urticaria |
4.6% |
| Atrial Fibrillation |
3.7% |
| Death |
3.7% |
| Gastric Polyps |
3.7% |
| Hypersensitivity |
3.7% |
| Neoplasm Malignant |
3.7% |
| Palpitations |
3.7% |
| Pharmaceutical Product Complaint |
3.7% |
| Acute Respiratory Failure |
2.8% |
| Chronic Obstructive Pulmonary Disease |
2.8% |
|
| Secondary |
| Gastrooesophageal Reflux Disease |
25.6% |
| Drug Use For Unknown Indication |
19.2% |
| Hypertension |
8.0% |
| Depression |
7.4% |
| Crohn's Disease |
4.9% |
| Irritable Bowel Syndrome |
3.9% |
| Product Used For Unknown Indication |
3.5% |
| Bipolar Disorder |
2.9% |
| Pain |
2.7% |
| Gastric Disorder |
2.5% |
| Insomnia |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Back Pain |
2.1% |
| Gastritis |
2.1% |
| Ill-defined Disorder |
2.1% |
| Thyroid Disorder |
1.9% |
| Diaphragmatic Hernia |
1.6% |
| Gastric Polyps |
1.6% |
| Osteoporosis |
1.6% |
| Fibromyalgia |
1.4% |
|
| Weight Decreased |
16.3% |
| Retinal Detachment |
9.3% |
| Drug Ineffective |
8.1% |
| Nephritis Interstitial |
7.0% |
| Drug Hypersensitivity |
4.7% |
| Groin Pain |
4.7% |
| Pain |
4.7% |
| Renal Impairment |
4.7% |
| Visual Impairment |
4.7% |
| Vitamin D Abnormal |
4.7% |
| Diarrhoea |
3.5% |
| Pain In Extremity |
3.5% |
| Tetany |
3.5% |
| Thrombosis |
3.5% |
| Visual Disturbance |
3.5% |
| Vitamin D Deficiency |
3.5% |
| Vomiting |
3.5% |
| Adverse Event |
2.3% |
| Asthma |
2.3% |
| Blood Cholesterol Increased |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.4% |
| Drug Use For Unknown Indication |
12.6% |
| Gastrooesophageal Reflux Disease |
10.4% |
| Hypertension |
6.5% |
| Pain |
5.8% |
| Depression |
4.6% |
| Osteoporosis |
3.8% |
| Asthma |
3.3% |
| Diabetes Mellitus |
3.1% |
| Rheumatoid Arthritis |
3.0% |
| Blood Cholesterol Increased |
3.0% |
| Anxiety |
2.5% |
| Crohn's Disease |
2.3% |
| Contraception |
2.1% |
| Arthritis |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Insomnia |
1.6% |
| Hypothyroidism |
1.6% |
| Hypersensitivity |
1.5% |
| Smoking Cessation Therapy |
1.5% |
|
| Weight Decreased |
13.1% |
| Vomiting |
12.3% |
| Weight Increased |
7.7% |
| Nausea |
6.9% |
| Pain |
6.7% |
| Drug Ineffective |
6.4% |
| Vision Blurred |
5.3% |
| Myocardial Infarction |
4.7% |
| Oedema Peripheral |
3.6% |
| Urinary Tract Infection |
3.4% |
| Pruritus |
3.4% |
| Tremor |
3.4% |
| Pulmonary Embolism |
3.3% |
| Dyspnoea |
3.2% |
| Pain In Extremity |
3.1% |
| Rash |
2.8% |
| Somnolence |
2.8% |
| Headache |
2.7% |
| Wheezing |
2.7% |
| Urticaria |
2.6% |
|
| Interacting |
| Pruritus |
25.0% |
| Abnormal Faeces |
8.3% |
| Hyperchlorhydria |
8.3% |
| Hypertension |
8.3% |
| Laxative Supportive Care |
8.3% |
| Smoking Cessation Therapy |
8.3% |
| Vertigo |
8.3% |
| Acute Myeloid Leukaemia |
4.2% |
| Depression |
4.2% |
| Fibromyalgia |
4.2% |
| Gastrooesophageal Reflux Disease |
4.2% |
| Hypersensitivity |
4.2% |
| Restless Legs Syndrome |
4.2% |
|
| Hair Texture Abnormal |
25.0% |
| Gastric Ph Increased |
12.5% |
| Gastrooesophageal Reflux Disease |
12.5% |
| Hormone Level Abnormal |
12.5% |
| Nightmare |
12.5% |
| Pain |
12.5% |
| Pruritus |
12.5% |
|
